Market closed

GlaxoSmithKline/GSK

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About GlaxoSmithKline

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Ticker

GSK

Trading on

LSE

Industry

Pharmaceuticals

Employees

70,212

GlaxoSmithKline Metrics

BasicAdvanced
£60B
Market cap
14.94
P/E ratio
£0.98
EPS
0.31
Beta
£0.59
Dividend rate
4.04%
Dividend yield
£60B
0.31
£18.24
£13.71
7.4M
£0.59
0.824
0.529
98.598
123.043
58.39%
13.55%
9.56%
33.30%
14.936
1.887
4.14
-7.39
11.365
4.04%
7.20%
-74.03%
3.48%
-3.45%
-15.66%

What the Analysts think about GlaxoSmithKline

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GlaxoSmithKline stock.

GlaxoSmithKline Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

GlaxoSmithKline Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy GSK

£

Sign up or log in to buy
Market closed

Upcoming events

Oct
10
GlaxoSmithKline
Dividend·Payment
£0.15
Per share

FAQs

What’s the current market cap for GlaxoSmithKline stock?

GlaxoSmithKline (GSK) has a market cap of £60B as of October 08, 2024.

What is the P/E ratio for GlaxoSmithKline stock?

The price to earnings (P/E) ratio for GlaxoSmithKline (GSK) stock is 14.94 as of October 08, 2024.

Does GlaxoSmithKline stock pay dividends?

Yes, the GlaxoSmithKline (GSK) stock pays dividends to shareholders. As of October 08, 2024, the dividend rate is £0.59 and the yield is 4.04%. GlaxoSmithKline has a payout ratio of 58.39% on a trailing twelve-month basis.

When is the next GlaxoSmithKline dividend payment date?

The next GlaxoSmithKline (GSK) dividend payment is scheduled for October 10, 2024.

What is the beta indicator for GlaxoSmithKline?

GlaxoSmithKline (GSK) has a beta rating of 0.31. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.